Preview

Neurology, Neuropsychiatry, Psychosomatics

Advanced search

Oral administration of cyanocobalamin for functional vitamin В12 deficiency: efficacy and safety

https://doi.org/10.14412/20742711-2021-4-109-115

Full Text:

Abstract

The prevalence of vitamin В12 deficiency is about 3—16% in the general population, while in older people, it ranges from 10 to 20%. An increase in the proportion of people on reduced-calorie diets, the widespread use of drugs that can result in vitamin В12 deficiency, an increase in life expectancy, on the one hand, a variety of clinical manifestations and the lack of precise algorithms for laboratory diagnostics, on the other hand, suggest that the number of patients with vitamin В12 deficiency is significantly higher. Vitamin В12 can be absorbed by passive diffusion, regardless of intrinsic factor and other underlying causes of the deficiency. The presence of an additional route of absorption brings in new expectations for the oral administration of cyanocobalamin in therapeutic doses. Comparative clinical trials of the use of cyanocobalamin have shown that the oral route of administration is as effective as the parenteral. Considering the need for long-term, and in some cases — life-long, use of the drug, there is a need to develop dosage regimens for oral administration comparable in effectiveness to parenteral administration. The use of functional vitamin В12 deficiency biomarkers, such as vitamin В12 levels, cholotranscobalamin, methylmalonic acid, homocysteine, made it possible to establish that a daily dose of 1000 mkg is the most effective, which at the initial stage is as efficient as intramuscular administration. In some circumstances, maintenance therapy (intramuscularly at a dose of 1 mg/month) was more effective; thus, a differentiated approach scheme to determining the maintenance oral dose was proposed, depending on the result obtained at the initial stage of therapy. Comparative studies covering the entire spectrum from the recommended dietary allowance to the dose commonly used for cobalamin injections have shown that an oral daily dose of 1000 mcg of cyanocobalamin normalizes serum vitamin В12 levels and causes an 80—90% decrease in plasma methylmalonic acid concentration from the assumed maximum value. The oral route of administration provides a higher patient treatment adherence.

About the Authors

E. V. Shikh
Department of Clinical Pharmacology and Internal Diseases Propedeutic, N.V. Sklifosovsky Institute of Clinical Medicine
Russian Federation

Evgeniya Valerievna Shikh.

8, Trubetskaya St., Build. 2, Moscow 119991.


Competing Interests:

The conflict of interest has not affected the results of the investigation.



Zh. M. Sizova
Department of Medical and Social Expertise, Emergency and Polyclinic Therapy, Institute of Professional Education
Russian Federation

49, Nakhimovsky prospect, Moscow 117418.


Competing Interests:

The conflict of interest has not affected the results of the investigation.



M. O. Astaeva
N.V. Sklifosovsky Institute of Clinical Medicine, I.M. Sechenov First Moscow State Medical University (Sechenov University), Ministry of Health of Russia
Russian Federation

8, Trubetskaya St., Build. 2, Moscow 119991.


Competing Interests:

The conflict of interest has not affected the results of the investigation.



References

1. Andres E, Dali-Youcef N, Vogel T, et al. Oral cobalamin (vitamin B(12)) treatment. An update. Int J Lab Hematol. 2009 Feb;31(1):1-8. doi: 10.1111/j.1751-553X.2008.01115.x

2. Andres E, Affenberger S, Vinzio S, et al. Food-cobalamin malabsorption in elderly patients: clinical manifestations and treatment. Am J Med. 2005 Oct;118(10):1154-9. doi: 10.1016/j.amjmed.2005.02.026

3. Jensen GL, Cederholm T, Correia MITD, et al. GLIM Criteria for the Diagnosis of Malnutrition: A Consensus Report From the Global Clinical Nutrition Community. JPEN J Parenter Enteral Nutr. 2019 Jan;43(1):32-40. doi: 10.1002/jpen.1440. Epub 2018 Sep 2.

4. Hannibal L, Lysne V, Monsen ALB. Biomarkers and algorithms for the diagnosis of vitamin B12 deficiency. Front Mol Biosci. 2016 Jun 27;3:27. doi: 10.3389/fmolb.2016.00027. eCollection 2016.

5. Grober U, Kisters К, Schmidt J. Neuroenhancement with Vitamin B12 — Underestimated Neurological Significance. Nutrients. 2013 Dec 12;5(12):5031-45. doi: 10.3390/nu5125031

6. Naik S, Mahalle N, Bhide V. Identification of vitamin B12 deficiency in vegetarian Indians. Brit J Nutr. 2018 Mar;119(6):629-35. doi: 10.1017/S0007114518000090. Epub 2018 Feb 15.

7. Fedosov SN, Brito A, Miller JW, et al. Combined indicator of vitamin B12 status: modifications for missing biomarkers and folate status and recommendations for revised cutpoints. Clin Chim Lab Med. 2015 Jul;53(8):1215-25. doi: 10.1515/cclm-2014-0818

8. Aroda V, Edelstein S, Goldberg R, et al. Long-term metformin use and vitamin B12 deficiency in the diabetes prevention program outcomes study. J Clin Endocrinol Metab. 2016 Apr;101(4):1754-61. doi: 10.1210/jc.2015-3754. Epub 2016 Feb 22.

9. Chapman LE, Darling AL, Brown JE. Association between metformin and vitamin B12 deficiency in patients with type 2 diabetes: A systematic review and meta-analysis. Diabetes Metab. 2016 Nov;42(5):316-27. doi: 10.1016/j.diabet.2016.03.008. Epub 2016 Apr 26.

10. Schrier S. Clinical manifestations and diagnosis of vitamin B12 and folate deficiency. Available from: https://www.uptodate.com/con-tents/clinical-manifestations-and-diagnosis-of-vitamin-b12-and-folate-deficiency

11. Kang D, Yun JS, Ko SH, et al. Higher prevalence of metformin-induced vitamin B12 deficiency in sulfonylurea combination compared with insulin combination in patients with type 2 diabetes: A cross-sectional study. PLoS One. 2014 Oct 9;9(10):e109878. doi: 10.1371/journal.pone.0109878. eCollection 2014.

12. Beulens J, Hart H, Kuijs R, et al. Influence of duration and dose of metformin on cobalamin deficiency in type 2 diabetes patients using metformin. Acta Diabetol. 2015 Feb;52(1):47-53. doi: 10.1007/s00592-014-0597-8. Epub 2014 Jun 8.

13. Herbert L, Ribar A, Mitchell S, et al. Discovering metformin-induced vitamin B12 deficiency in patients with type 2 diabetes in primary care. J Am Assoc Nurse Pract. 2019 Oct 20;33(2):174-80. doi: 10.1097/JXX.0000000000000312

14. American Diabetes Association. Standards of medical care in diabetes. Diabetes Care. 2017;41 Suppl 1. Available from: http://care.diabetesjournals.org/content/diacare/suppl/2017/12/08/41.Supplement_1.DC1/DC_41_S1_Combined.pdf

15. Kancherla V, Elliott J, Patel B, et al. Longterm metformin therapy and monitoring for vitamin B12 deficiency among older veterans. J Am Geriatr Soc. 2017 May;65(5):1061-6. doi: 10.1111/jgs.14761. Epub 2017 Feb 9.

16. Sanz-Cuesta T, Escortell-Mayor E, Cura-Gonzalez I, et al. Oral versus intramuscular administration of vitamin B12 for vitamin B12 deficiency in primary care: a pragmatic, randomised, non-inferiority clinical trial (OB12). BMJ Open. 2020 Aug 20;10(8):e033687. doi: 10.1136/bmjopen-2019-033687

17. Wang H, Li L, Qin LL, et al. Oral vitamin B12 versus intramuscular vitamin B12 for vitamin B12 deficiency. Cochrane Database Syst Rev. 2018 Mar 15;3(3):CD004655. doi: 10.1002/14651858.CD004655.pub3

18. Saraswathy AR, Dutta A, Simon EG, et al. Sa1100 randomized open label trial comparing efficacy of oral versus intramuscular vitamin B12 supplementation for treatment of vitamin B12 deficiency. Gastroenterology. 2012;142:S-216.

19. Moleiro J, Mao de Ferro S, Ferreira S, et al. Efficacy of long- term oral vitamin B12 supplementation after total gastrectomy: results from a prospective study. GE Port J Gastroenterol. 2018 Apr;25(3):117-22. doi: 10.1159/000481860. Epub 2017 Nov 8.

20. Bensky MJ, Ayalon-Dangur I, Dangur R, et al. Comparison of sublingual vs. intramuscular administration of vitamin B12 for the treatment of patients with vitamin B12 deficiency. Drug Deliv Transl Res. 2019 Jun;9(3):625-30. doi: 10.1007/s13346-018-00613-y

21. Eussen SJ, de Groot LC, Clarke R, et al. Oral cyanocobalamin supplementation in older people with vitamin B12 deficiency: a dose-finding trial. Arch Intern Med. 2005 May 23;165(10):1167-72. doi: 10.1001/archinte.165.10.1167

22. Rajan S, Wallace JI, Brodkin KI, et al. Responseof elevated methylmalonic acid to three dose levels of oral cobalamin in older adults. J Am Geriatr Soc. 2002 Nov;50(11):1789-95. doi: 10.1046/j.1532-5415.2002.50506.x

23. Green R, Allen LH, Bjorke-Monsen AL, et al. Vitamin B12 deficiency. Nat Rev Dis Primers. 2017 Jun 29;3:17040. doi: 10.1038/nrdp.2017.40

24. Fanidi A, Carreras-Torres R, Larose TL, et al. Is high vitamin B12 status a cause of lung cancer? Int J Cancer. 2019 Sep 15;145(6):1499-503. doi: 10.1002/ijc.32033. Epub 2019 Jan 15.

25. Brasky TM, Ray RM, Navarro SL, et al. Supplemental one-carbon metabolism related B vitamins and lung cancer risk in the Women's Health Initiative. Int J Cancer. 2020 Sep 1;147(5):1374-84. doi: 10.1002/ijc.32913. Epub 2020 Feb 25.

26. Flores-Guerrero JL, Minovic I, Groothof D, et al. Association of plasma concentration of vitamin B12 with all-cause mortality in the general population in the Netherlands. JAMA Netw Open. 2020 Jan 3;3(1):e1919274. doi: 10.1001/jamanetworkopen.2019.19274

27. Robinson DJ, O'Luanaigh C, Tehee E, et al. Vitamin B12 status, homocysteine and mortality amongst communitydwelling Irish elders. Ir J Med Sci. 2011 Jun;180(2):451-5. doi: 10.1007/s11845-010-0639-3. Epub 2010 Nov 13.

28. Gopinath B, Flood VM, Rochtchina E, et al. Serum homocysteine and folate but not vitamin B12 are predictors of CHD mortality in older adults. Eur J Prev Cardiol. 2012 Dec;19(6):1420-9. doi: 10.1177/1741826711424568. Epub 2011 Sep 29.

29. Bruce HR, Wolffenbuttel M, Heiner-Fokkema R, et al. Relationship between serum B12 concentrations and mortality: experience in NHANES. BMC Med. 2020 Oct 9;18(1):307. doi: 10.1186/s12916-020-01771-y

30. Rafnsson SB, Saravanan P, Bhopal RS, et al. Is a low blood level of vitamin B12 a cardiovascular and diabetes risk factor? A systematic review of cohort studies. Eur J Nutr. 2011 Mar;50(2):97-106. doi: 10.1007/s00394-010-0119-6. Epub 2010 Jun 29.

31. Pusceddu I, Herrmann W, Kleber M, et al. Telomere length, vitamin B12 and mortality in persons undergoing coronary angiography: the Ludwigshafen risk and cardiovascular health study. Aging (Albany NY). 2019 Sep 6;11(17):7083-97. doi: 10.18632/aging.102238. Epub 2019 Sep 6.


For citation:


Shikh E.V., Sizova Zh.M., Astaeva M.O. Oral administration of cyanocobalamin for functional vitamin В12 deficiency: efficacy and safety. Neurology, Neuropsychiatry, Psychosomatics. 2021;13(4):109-115. (In Russ.) https://doi.org/10.14412/20742711-2021-4-109-115

Views: 106


Creative Commons License
This work is licensed under a Creative Commons Attribution 4.0 License.


ISSN 2074-2711 (Print)
ISSN 2310-1342 (Online)